CHHHS Research & Innovation Symposium: Program

Prof Sarnyai discovered the efficacy of ketogenic metabolic therapy in preclinical models of schizophrenia and is currently conducting the world’s first randomised controlled clinical trial to investigate this clinical population. He is the Director of the newly established Margaret Roderick Centre for Mental Health Research at James Cook University.

He works part-time for Queensland Aboriginal and Islander Health Council as Principal Research Advisor. For over 20 years, he has collaborated nationally, and internationally to translate research for a clinical benefit. He has extensive experience in stakeholder engagement, community consultation, and co-design, and a track record leading policy development and research for a First Nations health benefit. His research focuses on realising equitable access to health research; focusing most recently on mental health and genomics.